198 related articles for article (PubMed ID: 34786336)
1. Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence.
Darwish I; Costiniuk C; Kronfli N; Haegert D; Routy JP
IDCases; 2021; 26():e01315. PubMed ID: 34786336
[TBL] [Abstract][Full Text] [Related]
2. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
3. Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease.
Rasmussen C; Gérard L; Fadlallah J; Corvilain E; Galicier L; Meignin V; Oksenhendler E; Boutboul D
Blood Adv; 2023 Sep; 7(18):5663-5669. PubMed ID: 37288720
[TBL] [Abstract][Full Text] [Related]
4. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
[TBL] [Abstract][Full Text] [Related]
5. Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease.
Kaga H; Kurahashi H; Kubota A; Hatano Y; Nanjo H; Wakui H; Takahashi N
Int J Hematol; 2022 Jan; 115(1):129-134. PubMed ID: 34591291
[TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection: A case report.
Guayboon T; Chinthammitr Y; Sukpanichnant S; Horthongkham N; Angkasekwinai N
Medicine (Baltimore); 2021 Dec; 100(49):e28077. PubMed ID: 34889256
[TBL] [Abstract][Full Text] [Related]
7. Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.
Pria AD; Pinato D; Roe J; Naresh K; Nelson M; Bower M
Blood; 2017 Apr; 129(15):2143-2147. PubMed ID: 28143881
[TBL] [Abstract][Full Text] [Related]
8. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
[TBL] [Abstract][Full Text] [Related]
9. Kaposi sarcoma herpesvirus/human herpesvirus 8-positive diffuse large B-cell lymphoma characterized by malignant ascites: A case report.
Chang LC; Fu PA; Wang SH; Chang KC; Hsu YT
Pathol Res Pract; 2024 Mar; 255():155185. PubMed ID: 38342036
[TBL] [Abstract][Full Text] [Related]
10. Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi.
Painschab MS; Mponda M; Tomoka T; Kampani C; Chimzimu F; Fedoriw Y; Gopal S
Front Oncol; 2022; 12():969135. PubMed ID: 36578926
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 8-positive multicentric Castleman disease with germinotropic plasmablastic aggregates: Overlapping spectrum of human herpesvirus 8-associated lymphoproliferative disorder.
Nakaya Y; Ishii N; Kasamatsu Y; Shimizu K; Tatsumi N; Tsutsumi M; Yoshida M; Yoshimura T; Hayashi Y; Nakao T; Inoue T; Yamane T
Pathol Int; 2020 Aug; 70(8):574-580. PubMed ID: 32449234
[TBL] [Abstract][Full Text] [Related]
12. A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab.
Plano F; Mancuso S; Camarda GM; Butera MG; Sucato G; Alecci G; Florena AM; Perrone S; Siragusa SM
Chemotherapy; 2024; 69(1):35-39. PubMed ID: 37634492
[TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus 8-related Castleman disease in the absence of HIV infection.
Dossier A; Meignin V; Fieschi C; Boutboul D; Oksenhendler E; Galicier L
Clin Infect Dis; 2013 Mar; 56(6):833-42. PubMed ID: 23223599
[TBL] [Abstract][Full Text] [Related]
14. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
[TBL] [Abstract][Full Text] [Related]
15. Does Kaposi's sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?
Alkaied H; Harris K; Elsayegh D; Khachaturova I; Awasum M; Varma S
Med Oncol; 2012 Jun; 29(2):1109-13. PubMed ID: 21472488
[TBL] [Abstract][Full Text] [Related]
16. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.
Oksenhendler E; Carcelain G; Aoki Y; Boulanger E; Maillard A; Clauvel JP; Agbalika F
Blood; 2000 Sep; 96(6):2069-73. PubMed ID: 10979949
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.
Ramaswami R; Lurain K; Polizzotto MN; Ekwede I; Waldon K; Steinberg SM; Mangusan R; Widell A; Rupert A; George J; Gonçalves PH; Marshall VA; Whitby D; Wang HW; Pittaluga S; Jaffe ES; Little RF; Uldrick TS; Yarchoan R
Blood Adv; 2021 Mar; 5(6):1660-1670. PubMed ID: 33720337
[TBL] [Abstract][Full Text] [Related]
19. Human Herpesvirus-8 (HHV-8)-Positive Human Immunodeficiency Virus (HIV)-Negative Multicentric Castleman Disease With a Fulminant Course.
Brito MT; Amador AF; Moço Coutinho R; Ribeiro A; Almeida JS
Cureus; 2024 Feb; 16(2):e54350. PubMed ID: 38500919
[TBL] [Abstract][Full Text] [Related]
20. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?
Sayer R; Paul J; Tuke PW; Hargreaves S; Noursadeghi M; Tedder RS; Grant P; Edwards SG; Miller RF
Int J STD AIDS; 2011 Oct; 22(10):585-9. PubMed ID: 21998180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]